Bracco, ImaRx sign licensing pact

AuntMinnie.com staff writers
Jul 3, 2007

Milan, Italy-based contrast agent developer Bracco and biopharmaceutical firm ImaRx Therapeutics of Tucson, AZ, have signed a cross-license agreement for certain patents and patent applications of each other's products.

ImaRx granted to Bracco worldwide, royalty free, nonexclusive rights for certain microbubble compositions solely for use in targeted diagnostic imaging applications.

In return, Bracco gave ImaRx the same rights, patents, and patent applications related to certain microbubble compositions solely for use in therapeutic applications.

By AuntMinnie.com staff writers
July 4, 2007

Related Reading

ImaRx files S-1 for IPO, May 5, 2007

Unger steps down at ImaRx, October 24, 2006

ImaRx buys Abbokinase, May 9, 2006

VisualSonics, Bracco partner, June 8, 2006

Bracco opens perfusion PET company, June 1, 2006

Copyright © 2007 AuntMinnie.com

Latest in Clinical News
Artificial Intelligence Ai Social
AI stroke software differences don't affect thrombectomy eligibility
May 3, 2024
IMV’s Oncology in Diagnostic Imaging Market Outlook Report
Sponsored
IMV’s Oncology in Diagnostic Imaging Market Outlook Report
March 15, 2024
2024 04 30 Scoliosis Ai Thumbnail
AI brings scoliosis monitoring on x-rays into modern era
May 1, 2024
Breast Cancer3
DBT + CEM boosts cancer detection in women with history of the disease
April 30, 2024
Related Stories
2007 07 03 15 48 55 706
CT
Cold case closed: CT solves iceman's cause of death
2007 07 02 14 26 46 706
MRI
MR shows broad spectrum of findings in pregnant women with suspected appendicitis
2007 06 29 16 24 07 706
CT
Hessian matrix-based CAD looks promising for VC
IMV’s Oncology in Diagnostic Imaging Market Outlook Report
Sponsor Content
IMV’s Oncology in Diagnostic Imaging Market Outlook Report
More in Clinical News
AI stroke software differences don't affect thrombectomy eligibility
By Liz Carey
The research findings suggest, however, that scanner model and local CT perfusion protocols can influence performance and cause discrepancies.
May 3, 2024
Artificial Intelligence Ai Social
Volumetric CT helps predict lung-lobectomy complications
By Kate Madden Yee
Volumetric CT imaging analysis shows promise for helping determine lung function in lung cancer patients undergoing pulmonary lobectomy.
May 1, 2024
Lung Cancer
AI brings scoliosis monitoring on x-rays into modern era
By Will Morton
An AI model has delivered a long overdue update of pediatric bone growth predictions used in x-ray imaging to monitor scoliosis.
May 1, 2024
2024 04 30 Scoliosis Ai Thumbnail
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
Risk of knee osteoarthritis may depend on muscle mass
By Will Morton
Physical activities like running may increase the risk of osteoarthritis in individuals with lower muscle mass surrounding the knee joints.
April 30, 2024
Knee Runner
USPSTF finalizes breast cancer screening recommendations
By Liz Carey
The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.
April 30, 2024
Mammogram Breast
Interstitial lung abnormalities linked to respiratory disease risk
By Kate Madden Yee
CT imaging shows that severe acute respiratory disease events can be caused by quantitative interstitial abnormalities.
April 30, 2024
2024 04 30 Radiology Choi Figure2 Thumbnail
Large language models underperform in breast imaging
By Amerigo Allegretto
Large language models such as ChatGPT and Google Gemini fall short in breast imaging.
April 30, 2024
Screenshot (1152)
U.S. federally qualified health centers show cancer screening gaps
By Kate Madden Yee
U.S. federally qualified health centers, intended to provide care to underserved populations across the country, show cancer screening gaps.
April 29, 2024
Breast Screening Mammo
PET reveals ‘smoldering’ brain inflammation in patients treated for MS
By Will Morton
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with therapies.
April 29, 2024
Individualized parametric z-score maps of the brain showing glial activity load in the brain, compared among individuals with secondary progressive MS (SPMS) (top row), relapsing-remitting MS (RRMS) (middle row), and a healthy control (HC) (bottom row) in transaxial, sagittal, and coronal sections. Image courtesy of Clinical Nuclear Medicine.
Understanding CT flow artifacts is key to better disease diagnosis
By Kate Madden Yee
Understanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.
April 26, 2024
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
Dual-tracer PET/CT shows promise in liver cancer patients
By Will Morton
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment.
April 26, 2024
Liver Cancer
Page 1 of 3589
Next Page